Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1398-1400

  Orvieto, Raoul ^a,b   Nahum, Ravit ^a   Rabinson, Jacob ^a   Gemer, Ofer ^a,b   Anteby, Eyal Y ^a,b   Meltcer, Simion ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EMBRYO CULTURE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; OVARY HYPERSTIMULATION; PRIORITY JOURNAL;

ADULT; CONTRACEPTIVES, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; LUTEOLYTIC AGENTS; PREGNANCY; PREGNANCY RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TRIPTORELIN;

EID: 63249094483     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.04.064     Document Type: Article

References (11)

1. Penzias A.S. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 9 (2004) 43-46
2. Ben-Rafael Z., Orvieto R., and Feldberg D. The poor-responder patient in an in-vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol 8 (1994) 277-286
3. Surrey E.S., and Schoolcraft W.B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73 (2000) 667-676
4. Barad D., and Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 21 (2006) 2845-2849
5. Ziebe S., Bangsboll S., Schmidt K.L.T., Loft A., Lindhard A., and Nyboe Andersen A. Embryo quality in natural versus stimulated IVF cycles. Hum Reprod 19 (2004) 1457-1460
6. Duvan C.I., Berker B., Turhan N.O., and Satiroglu H. Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients. J Assist Reprod Genet 25 (2008) 89-93
7. Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S. Ultrashort GnRH-agonist combined with flexible multidose GnRH-antagonist for poor-responders in IVF-ET programs. Fertil Steril. In press.
8. Ziebe S., Lundin K., Janssens R., Helmgaard L., Arce J.C., and MERIT Group. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod 22 (2007) 2404-2413
9. Takahashi K., Mukaida T., Tomiyama T., Goto T., and Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet 21 (2004) 317-322
10. Keltz M.D., Gera P.S., Skorupski J., and Stein D.E. Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization. Fertil Steril 88 (2007) 350-353
11. Surrey E., Bower J., Hill D., Ramsey J., and Surrey M. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424